VIDEOS

Patients that may benefit from addition of an ICS  

02:02

Patients that may benefit from addition of an ICS
ICS usage and eosinophil count as biomarker in COPD patients  

02:17

ICS usage and eosinophil count as biomarker in COPD patients
Gold Update 2019: Prof. Vogelmeier  

08:30

Gold Update 2019: Prof. Vogelmeier
Mode Of Action Video  

02:52

COPD Video
Benefits of ARBs in the Treatment of Hypertension  

06:20

Benefits of ARBs in the Treatment of Hypertension
Prof Ryner: Controversies in Hypertension  

06:52

Prof Ryner: Controversies in Hypertension
38% relative risk reduction in CV death with Jardiance  

01:01

38% relative risk reduction in CV death with Jardiance
CV Reduction was generally consistent across baseline HbA1c  

0:58

CV Reduction was generally consistent across baseline HbA1c
Patients could live longer with Jardiance  

0:59

Patients could live longer with Jardiance
Relative risk reduction of CV death by more than 1/3  

01:01

Relative risk reduction of CV death by more than 1/3
Early impact on risk reduction of CV death  

01:01

Early impact on risk reduction of CV death
32% Relative risk reduction in all-cause mortality  

01:01

32% Relative risk reduction in all-cause mortality
Reduction of CV death was achieved ontop of standard of care  

01:03

Reduction of CV death was achieved ontop of standard of care
35% Relative reduction in hospitilization for heart failure  

01:01

35% Relative reduction in hospitilization for heart failure
Actilyse Reconstitution Video  

01:24

Actilyse Reconstitution Video
Mode of Action Video  

01:24

Mode of Action Video
DR DUIM: ACUTE STROKE MANAGEMENT  

21:08

DR DUIM: ACUTE STROKE MANAGEMENT
Dr. Todd C.Villines: Pradaxa vs other NOACs  

03:36

Dr. Todd C.Villines: Pradaxa vs other NOACs
Life happens: Car accidents  

00:32

Life happens: Car accidents
Life happens: How emergency situations affect life of patients on OAC treatment  

00:49

Life happens: How emergency situations affect life of patients on OAC treatment
Life happens: Appendicitis is one of the most frequent abdominal surgical emergencies  

00:42

Life happens: Appendicitis is one of the most frequent abdominal surgical emergencies
Idarucizumab (Praxbind®) patient case in gallbladder removal  

01:29

Idarucizumab (Praxbind®) patient case in gallbladder removal
Idarucizumab (Praxbind®) real patient cases  

03:00

Idarucizumab (Praxbind®) real patient cases
Reversibility of NOAC therapies: the neurologist's perspective  

06:12

Reversibility of NOAC therapies: the neurologist's perspective
Dosage & Administration  

01:18

Dosage & Administration
Praxbind Administration  

02:03

Praxbind Administration
Mode of Action Video  

01:01

Mode of Action Video
Mode of Action Video 

02:53

Mode of Action Video
Thrive Summit Overview 

05:36

Thrive Summit Overview
Dr. Bhana – TDM: Current Treatment Therapies 

31:27

Dr. Bhana – TDM: Current Treatment Therapies
NOACS What The Past 5 Years Taught Us  

03:16

NOACS What The Past 5 Years Taught Us
BID vs Once Daily Dosing  

01:17

BID vs Once Daily Dosing
NOAC safety in clinical practice: Evidence from the real world  

06:52

NOAC safety in clinical practice: Evidence from the real world
GLORIA-AF Info Graphic video  

02:52

GLORIA-AF Info Graphic video
Pradaxa Real Patient Cases  

02:58

Pradaxa Real Patient Cases
From Clinical Trials To RWE info Graphic Video  

03:50

From Clinical Trials To RWE info Graphic Video
Load more

Clinical studies

WISDOM Trial

icoPDF

WISDOM Trial
UPLIFT Clinical Trial Summary

icoPDF

UPLIFT Clinical Trial Summary
COPD Treatment: GOLD Guidelines Infographic

icoPDF

COPD Treatment: GOLD Guidelines Infographic
Spiriva Exacerbation Data vs Anoro

icoPDF

Spiriva Exacerbation Data vs Anoro
Spiriva vs Salmeterol: Time to first excacerbation

icoPDF

Spiriva vs Salmeterol: Time to first excacerbation
Spiriva vs Salmeterol: Severe Excacerbation data

icoPDF

Spiriva vs Salmeterol: Severe Excacerbation data
COPD Symptom Checker

icoPDF

COPD Symptom Checker
Surgical Intervention

icoPDF

Surgical Intervention
Indication and Dosage

icoPDF

Indication and Dosage
Risk vs Benefit

icoPDF

Risk vs Benefit
Precautions When Using Actilyse

icoPDF

Precautions When Using Actilyse
Minimising the Risk of Bleeding

icoPDF

Minimising the Risk of Bleeding
Monitoring for Major and Minor Bleeding

icoPDF

Monitoring for Major and Minor Bleeding
Risk Factors for ICH

icoPDF

Risk Factors for ICH
Bleed Management Overview

icoPDF

Bleed Management Overview
AHA/ASA Recommendations for Managing sICH

icoPDF

AHA/ASA Recommendations for Managing sICH
AHA/ASA: Reversal Agents

icoPDF

AHA/ASA: Reversal Agents
Contra-indications

icoPDF

Contra-indications
Telmisartan unique attributes

icoPDF

Telmisartan unique attributes
24 Hour BP Control

icoPDF

24 Hour BP Control
Cardio metabolic patients

icoPDF

Cardio Metabolic Patients
ONTARGET trial

icoPDF

ONTARGET trial
Telmisartan unique attributes

icoPDF

Telmisartan unique attributes
24 Hour BP Control

icoPDF

24 Hour BP Control
Cardio metabolic patients

icoPDF

Cardio Metabolic Patients
Guidelines for the management of Acute Ischaemic Stroke

icoPDF

Guidelines for the management of Acute Ischaemic Stroke
Endovascular Therapy

icoPDF

Endovascular Therapy
Actilyse Stroke - Act FAST

icoPDF

Actilyse Stroke - Act FAST
The increasing burden of stroke

icoPDF

The increasing burden of stroke
The importance of treating stroke as an emergency

icoPDF

The importance of treating stroke as an emergency
Early treatment of stroke is great benefit to your patient

icoPDF

Early treatment of stroke is great benefit to your patient
Clinical presentation, diagnosis, and management of pulmonary embolism

icoPDF

Clinical presentation, diagnosis, and management of pulmonary embolism
Atrial fibrillation and stroke

icoPDF

Atrial fibrillation and stroke
An overview of Atrial Fibrillation (AF)

icoPDF

An overview of Atrial Fibrillation (AF)
Stroke prevention in Atrial Fibrillation (AF)

icoPDF

Stroke prevention in Atrial Fibrillation (AF)
Mechanisms of anticoagulation

icoPDF

Mechanisms of anticoagulation
Managament of deep vein thrombosis

icoPDF

Managament of deep vein thrombosis
INPULSIS-ON
Efficacy
Reimbursement Information
Reimbursement Information
Dosage
Dosage
INPULSIS-ON
Mechanism of Action
Pradaxa:Mechanism of Action
Pradaxa:Mechanism of Action
RE-DUAL PCI

icoPDF

RE-DUAL PCI
Safety & Tolerability
Safety & Tolerability
Load more

BI LEARNING

Ethics: Distributive Justice
Ethics: Distributive Justice
Ethics: Professionalism Ethics
Ethics: Professionalism Ethics
Hypertension 1
Hypertension 1
Hypertension 2
Hypertension 2
Load more